Clobetasol: Price, Dosage & Where to Buy

Clobetasol is a super-high potency topical corticosteroid used to relieve inflammation and itching associated with skin conditions that respond to corticosteroids. The cream is intended for short-term treatment, with treatment stopped when the condition is controlled because prolonged use can cause effects beyond the skin. Clobetasol requires a prescription in the United Kingdom and is available as a generic medicine.

Clobetasol propionate cream is indicated for the relief of inflammation and itching caused by corticosteroid-responsive skin conditions. This means skin disorders whose inflammatory symptoms respond to corticosteroid treatment; the label does not name individual conditions. Treatment is intended to be short term and should end when control has been achieved.

If there is no improvement within 2 weeks, the label states that reassessment of the diagnosis may be necessary. Use in children under 12 years of age is not recommended.

The label lists topical cream strengths of 0.25 mg/g and 0.5 mg/g, with the cream treatment directions referring to clobetasol propionate 0.05%. The label lists a thin layer on affected skin areas twice daily, rubbed in gently and completely. The label lists a treatment limit of 2 consecutive weeks and a maximum total amount of 50 g/week.

Treatment should be discontinued when control has been achieved, and lack of improvement warrants reassessment. The cream should not be used with occlusive dressings.

The label lists no dosage adjustment for older patients. These cream directions do not describe dosing for the other available formulations.

Clobetasol belongs to the corticosteroid class of medicines. These medicines act within cells to reduce the production and activity of substances involved in inflammation. When used on the skin, this action helps reduce inflammatory symptoms such as itching.

Clobetasol cream is described as super-high potency, meaning it has a strong corticosteroid effect. Some medicine can also pass through the skin into the bloodstream, which explains why topical treatment can sometimes affect the body's normal hormone regulation.

There are no adequate, well-controlled studies of clobetasol propionate's potential to cause fetal abnormalities in pregnant women. Animal studies found fetal harm and developmental abnormalities following systemic administration; topical clobetasol has not been tested for this effect, although it can be absorbed through the skin.

The label states that the cream should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. The label does not specify breastfeeding information, so breastfeeding use should be discussed with a doctor or pharmacist.

For a missed topical corticosteroid application, general pharmacy guidance is to resume the usual schedule rather than use extra cream to compensate. If the next scheduled application is near, the missed application is usually skipped. A pharmacist can clarify how this applies to the prescribed treatment course.

The label states that the cream should be stored between 15° and 30°C and should not be refrigerated. Keep it out of the sight and reach of children, and follow the storage wording on the pack to maintain quality.